ClinicalTrials.gov record
Recruiting Phase 2 Interventional

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

ClinicalTrials.gov ID: NCT06773910

Public ClinicalTrials.gov record NCT06773910. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 4:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized Study of BMS-986489 (Atigotatug + Nivolumab Fixed-dose Combination) vs Durvalumab as Consolidation Therapy Following Chemoradiotherapy in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Study identification

NCT ID
NCT06773910
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
SCRI Development Innovations, LLC
Other
Enrollment
250 participants

Conditions and interventions

Interventions

  • BMS-986489 Drug
  • Durvalumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 10, 2025
Primary completion
Apr 30, 2032
Completion
Aug 31, 2032
Last update posted
Apr 21, 2026

2025 – 2032

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
33
Facility City State ZIP Site status
Southern Cancer Center Daphne Alabama 36526 Recruiting
Sansum Clinic Santa Barbara California 93105 Recruiting
Florida Cancer Specialists - South Fort Myers Florida 33901 Recruiting
University of Miami - Sylvester Cancer Center Miami Florida 33136 Active, not recruiting
Ocala Oncology Center Ocala Florida 34474 Recruiting
Florida Cancer Specialists - North Orange City Florida 32763 Recruiting
Cancer Care Centers of Brevard Palm Bay Florida 32901 Recruiting
Florida Cancer Specialists - East West Palm Beach Florida 33401 Recruiting
Piedmont Healthcare - Atlanta Atlanta Georgia 30309 Recruiting
Illinois Cancer Specialists Arlington Heights Illinois 60005 Recruiting
Illinois Cancer Care Peoria Illinois 61615 Recruiting
Indiana University Simon Cancer Center Indianapolis Indiana 46202 Recruiting
Baptist Health - Corbin Corbin Kentucky 40701 Recruiting
Baptist Health - Lexington Lexington Kentucky 40503 Recruiting
Baptist Health - Louisville Louisville Kentucky 40207 Recruiting
Minnesota Oncology Hematology Maple Grove Minnesota 55369 Recruiting
Missouri Cancer Associates Columbia Missouri 65201 Recruiting
White Plains Hospital Physician Associates White Plains New York 10601 Recruiting
Carolina Cancer Research Center Wilson North Carolina 27896 Recruiting
Oncology Hematology Care Cincinnati Ohio 45242 Recruiting
Mid Ohio Hem/ Onc dba The Mark H Zangmeister Center Columbus Ohio 43219 Recruiting
Oncology Associates of Oregon (Willamette Valley Cancer Institute and Research Center) Eugene Oregon 97401 Recruiting
Tennessee Cancer Specialists Knoxville Tennessee 37909 Recruiting
SCRI Oncology Partners Nashville Tennessee 37203 Recruiting
Texas Oncology - West Texas Amarillo Texas 79124 Recruiting
Texas Oncology- Austin Austin Texas 78705 Recruiting
Texas Oncology - Gulf Coast Beaumont Texas 77702 Recruiting
Texas Oncology - DFW Dallas Texas 75246 Recruiting
Texas Oncology - Northeast Texas Denison Texas 75020 Recruiting
Texas Oncology - San Antonio San Antonio Texas 78240 Recruiting
Virginia Cancer Specialists Fairfax Virginia 22031 Recruiting
Virginia Oncology Associates Norfolk Virginia 23502 Recruiting
Blue Ridge Cancer Center (Oncology & Hematology Associates of Southwest VA) Salem Virginia 24153 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06773910, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06773910 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →